July 8, 2011 (Paris, France, and New York, New York) — The issue of bleeding in ACS or PCI patients continues to be the focus of much attention, with two new consensus papers published in recent weeks--one in Europe, the other in the US--and a new standardized definition of bleeding proposed for use in cardiovascular clinical trials.
An author of the new European consensus paper [1], published online June 29, 2011 in the European Heart Journal, Dr Gabriel Steg (Centre Hospitalier Bichaut-Claude Bernard, Paris, France), commented to heartwire : "Our paper together with the US paper and the proposed new definition together show how bleeding is gaining in importance in the ACS and PCI field. It used to be thought that bleeding was unimportant, and everyone was completely focused on reduction of ischemic complications. If patients bled, they would just be transfused, and it was thought that would deal with it. But now there is a growing realization that bleeding is not just a benign side effect but that people who bleed are at higher risk of death. The jury is still out on whether bleeding is actually causal for mortality or not, but data are building up implicating a harmful effect of bleeding."/.../
No comments:
Post a Comment